Globe Life price target raised to $106 from $105 at Piper Sandler

Piper Sandler raised the firm’s price target on Globe Life to $106 from $105 and keeps an Overweight rating on the shares. Health drove the beat while distribution in Life and Health was strong with agents, sales and 2024 EPS guidance increasing, the analyst tells investors in a research note. The DOJ and SEC inquiries are likely to remain an overhang throughout the next several quarters, the firm says.